1Mahnke K, Schmitt E, Bonifaz L, et al. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol, 2002, 80:477-483.
2Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.J Exp Med, 1992, 176:1693-1702.
3Hirano A, Luke PP, Specht SM, et al. Graft hyporeactivity induced by immature donor-derived dendritic cells. Transpl Immunol, 2000, 8:161-168.
4Liu T, Matsuguchi T, Tsuboi N, et al. Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun, 2002, 70: 6638-6645.
5Nouri-Shirazi M, Guinet E. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation, 2002, 74: 1035-1044.
6Jonuleit H, Schmitt E, Steinbrink K, et al. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol,2001, 22: 394-400.
7Hackstein H, Morelli AE, Thomson AW. Designer dendritic cells for tolerance induction: guided not misguided missiles.Trends Immunol, 2001, 22:437-442.
8Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med, 2001, 194:863-869.
9Zhang H, Tay PN, Cao W, et al. Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling.FEBS Lett, 2002, 532:171-176.
10Takeuchi J, Watari E, Shinya E, et al. Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem Biophys Res Commu
1Sallusto F, Lanzavecchia A. Heterogeneity of CD4^+ memory T cells: functional modules for tailored immunity [ J ]. Eur J Immunol, 2009, 39 (8) :2076 -2082.
2Noma T. Helper T cell paradigm : Thl 7 and regulatory T cells involved in autoimmune inflammatory disorders, pathogen defense and allergic dis- eases[J]. Nihon Rinsho Meneki Gakkai Kaishi, 2010, 33 (5):262 -271.
3Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4 ^+ CD25^+ naive T cells to CD4 ^+ CD25 ^+ regulatory T cells by TGF-beta induetion of transcription factor Foxp3 [ J ]. J Exp Med, 2003, 198 (12) :1875 - 1886.
4Fujita-Sato S, Ito S, lsobe T, et al. Structural basis of digoxin that an- tagonizes RORgamma t receptor activity and suppresses Thl7 cell differ- entiation and interleukin (IL)-17 produetion[ J]. J Biol Chem, 2011, 286(36) :31409 -31417.
5Yagi R, Junttila IS, Wei G, et al. The transcription factor GATA3 ae- tively represses RUNX3 protein-regulated productlon of interferon-'y [J]. Immunity, 2010, 32(4) :507 -517.
6Beriou G, Costantino CM, Ashley CW, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function [ J ]. Blood, 2009, 113 ( 18 ) :4240 - 4249.
7Li L, Patsoukis N, Petkova V, et al. Runxl and Runx3 are involved in the generation and function of highly suppressive IL-17-prnducing T reg- ulatory cells[J]. PloS one, 2012, 7(9) :e45115.
8Apel M, Uebe S, Bowes J, et al susceptibility to psoriatic arthritis, Variants in RUNX3 contribute to exhibiting further common ground with ankylosing spondylitis [ J]. Arthritis & Rheumatism, 2013, 65 (5) :1224 - 1231.
9Tsoi LC, Spain SL, Knight J, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity [ J ]. Nature genetics, 2012, 44(12) : 1341 - 1348.
10Wing K, Sakaguehi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity [ J ]. Nature immunology, 2010, 1 1 (1):7-13.
